Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:34 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 2,293 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiac Ischemia Clear all

Conditions: Cancer, Chemotherapeutic Toxicity, Coronary Artery Disease, Coronary Microvascular Disease
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Coronary Artery Stenosis
Interventions: BioNIR, Resolute; Device
Lead sponsor: Medinol Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 1,919 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetes, Dyslipidemia, Hypertension, Coronary Atherosclerosis
Interventions: Counseling, Interactive Education, Group Support, Pharmacologic case management; Behavioral · Procedure
Lead sponsor: Providence VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Coronary Artery Disease
Interventions: IMPLELLA LP 2.5, IABP Intra-aortic balloon pump; Device
Lead sponsor: Abiomed Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 44
States / cities: Birmingham, Alabama • Gilbert, Arizona • Phoenix, Arizona + 35 more

Conditions: Myocardial Infarction
Interventions: abciximab placebo; reteplase placebo, abciximab, abciximab, Abciximab; reteplase; abciximab placebo; abciximab, abciximab; reteplase placebo; abciximab placebo; abciximab; Drug
Lead sponsor: Centocor, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 2,461 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 52
States / cities: Phoenix, Arizona • Covina, California • Modesto, California + 49 more

Conditions: Acute Coronary Syndromes
Interventions: rosuvastatin calcium, atorvastatin; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 825 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 52
States / cities: San Diego, California • Torrance, California • Bridgeport, Connecticut + 49 more

Conditions: Coronary Artery Disease
Interventions: Methylnaltrexone, Placebo, Morphine, Ticagrelor; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Coronary Artery Disease, Microvascular Coronary Artery Disease
Interventions: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance; Diagnostic Test
Lead sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Other
Eligibility: 18 Years and older
Enrollment: 2,322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Ischemic Heart Disease
Interventions: Not listed
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2002
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Coronary Artery Disease
Interventions: dipyridamole; Drug
Lead sponsor: UConn Health; Other
Eligibility: 21 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Coronary Disease
Interventions: Not listed
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Coronary Artery Disease, Heart Disease, Healthy
Interventions: Not listed
Lead sponsor: Fairbanks Institute; Other
Eligibility: 18 Years and older
Enrollment: 1,400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 14
States / cities: Avon, Indiana • Brownsburg, Indiana • Franklin, Indiana + 6 more

Conditions: Myocardial Ischemia
Interventions: Magnetocardiograph; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Telemetry Usage, Chest Pain, Unstable Angina, Resource Utilization
Interventions: Telemetry, Unmonitored; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Atrial Fibrillation
Interventions: AFSW Guided DOAC, Continuous DOAC therapy; Device · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 85 Years
Enrollment: 5,350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 93
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 68 more

Conditions: Myocardial Ischemia
Interventions: Magnetocardiograph; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 45 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Cardiovascular Disease
Interventions: Education; Behavioral
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 92,057 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 14
States / cities: Long Beach, California • San Francisco, California • New Haven, Connecticut + 10 more

Conditions: Atherosclerosis, Endothelial Function
Interventions: Nebivolol, Atenolol; Drug
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 79 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Heart Defects, Congenital
Interventions: Dexrazoxane; Drug
Lead sponsor: Medical City Children's Hospital; Other
Eligibility: 1 Day to 6 Months
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Atrial Fibrillation, Stroke, Stroke, Cardiovascular, Vascular Cognitive Impairment, Strokes Thrombotic, Stroke, Ischemic
Interventions: Cardiac and Brain MRI; Device
Lead sponsor: Tulane University; Other
Eligibility: 18 Years to 120 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: Corewell Health West; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Coronary Artery Disease, Acute Coronary Syndrome
Interventions: BrightHeart®; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Coronary Artery Disease
Interventions: Patent hemostasis and heparin; Other
Lead sponsor: Olivier F. Bertrand; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Scranton, Pennsylvania

Conditions: Ventricular Tachycardia (VT)
Interventions: Antiarrythmic Drug Therapy, Catheter ablation; Drug · Procedure
Lead sponsor: John Sapp; Other
Eligibility: 18 Years and older
Enrollment: 416 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 2
States / cities: Hartford, Connecticut • Nashville, Tennessee

Search by objective public record fields.

Serial PET MPI in Patients Undergoing Cancer Treatment

Study of BioNIR Drug Eluting Stent System in Coronary Stenosis

Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic

Protect II, A Prospective, Multicenter Randomized Controlled Trial

A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine

Inclusive Invasive Physiological Assessment in Angina Syndromes Registry

Implementation of Ischemic Heart Disease Clinical Practice Guidelines

Persantine: Variation in Response Trial

Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease

Biorepository: Indiana Health Study

Efficacy of the CMI Magnetocardiograph in Diagnosing Acute Coronary Syndromes in Patients Presenting With High Risk Unstable Angina.

A Randomized Trial of Telemetry Compared With Unmonitored Floor Admissions in ED Patients With Low-Risk Chest Pain

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Precision of the Magnetocardiographer for Data Aquision and Analysis.

Implementation of Practice Standards for ECG Monitoring

Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques

Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery: Proposal for Pilot Investigation

Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study

Intracoronary Imaging With NIRS-IVUS to Characterize Arterial Plaques

Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease

A-priori Versus Provisional Heparin on Radial Artery Occlusion After Transradial Coronary Angiography and Patent Hemostasis

Antiarrhythmics or Ablation for Ventricular Tachycardia 2